Please login to the form below

Not currently logged in
Email:
Password:

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

Ruth Currie, Chugai UKChugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business.

Currie takes over from John Halls, who also receives a promotion that sees him become managing director for Chugai's commercial activities across Europe.

In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche since 2002. She will also join Chugai's European leadership team.

Currie has been with Chugai, the original developers of RoAcemtra, since 2009, holding several senior positions, including most recently as UK sales director.

11th February 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics